Anthracyclines in the treatment of early-stage breast cancer: ally or adversary?
Lyman
Gary H
GH
Duke Comprehensive Cancer Center, Duke University, Durham, North Carolina 27705, USA. gary.lyman@duke.edu
D018943:Anthracyclines / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D001943:Breast Neoplasms / Q000188:drug therapy*; D017024:Chemotherapy, Adjuvant; D002986:Clinical Trials as Topic; D005260:Female; D006801:Humans; D009367:Neoplasm Staging
D018943:Anthracyclines